Etravirine Pharmacokinetics In HIV-Infected Pregnant Women
Background: The study goal was to describe etravirine pharmacokinetics during pregnancy and postpartum in HIV-infected women. Methods: IMPAACT P1026s and PANNA are on-going, nonrandomized, open-label, parallel-group, multi-center phase-IV prospective studies in HIV-infected pregnant women. Intensive...
Main Authors: | Nikki Mulligan, Stein Schalkwijk, Brookie M. Best, Angela Colbers, Jiajia Wang, Edmund V. Capparelli, José Moltó, Alice M. Stek, Graham Taylor, Elizabeth Smith, Carmen Hidalgo-Tenorio, Nahida Chakhtoura, Marjo van Kasteren, Courtney V. Fletcher, Mark Mirochnick, David Burger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00239/full |
Similar Items
-
Development of a practical synthesis of etravirine via a microwave-promoted amination
by: Da Feng, et al.
Published: (2018-12-01) -
Efficacy and safety of darunavir and etravirine in a patient with retroviruses and multiple virologic failure
by: Claudia Bernardini, et al.
Published: (2009-09-01) -
Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens
by: Valérie Potard, et al.
Published: (2018-07-01) -
Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection
by: Rosso R, et al.
Published: (2009-03-01) -
Pharmacoeconomic analysis of the etravirine compared to raltegravir in treatment HIV-infected adult patients, previously treated with antiretroviral drugs
by: Y. I. Ashikhmin, et al.
Published: (2018-05-01)